SupplierRadar

Shandong Yuwang Pharmaceutical Co., Ltd

FDA import alert and refusal historyDezhou, ChinaFEI 3010119104

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Shandong Yuwang Pharmaceutical Co., Ltd.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectShandong Yuwang Pharmaceutical Co., Lt added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

As of October 26, 2026, Shandong Yuwang Pharmaceutical Co., Ltd is not on any FDA import alert in SupplierRadar's records; FDA refused 3 of its shipment lines between December 6, 2021 and March 15, 2022, most often for ingredients not listed (LIST INGRE).

Data from FDA public records, last checked . Request a correction

Current status

Import alerts
Not listed
Last import refusal
Herbals & botanical teas, n.e.c. · LIST INGRE
Last warning letter
None found
Last inspection
Classified VAI (Voluntary Action Indicated)

Every FDA record for Shandong Yuwang Pharmaceutical Co., Ltd

4 records, newest first. Each line links to the FDA page it came from.

2022

  1. Import refusal
    Refused, 2 lines in one entry: Herbals & botanical teas, n.e.c.; Vitamin e (tocopherol)LIST INGREEntry 9UA-0271507-8Show 2 lines
    Source

2021

  1. Import refusal
    Refused, Herbals & botanical teas, n.e.c.LIST INGRELABELINGEntry 9UA-0265973-0
    Source

2018

  1. Inspection
    Inspection classified VAI (Voluntary Action Indicated)Food Composition, Standards, Labeling and Econ; Foodborne Biological Hazards
    Source

Refusal charges, in plain English

  • LIST INGRE3 refused lines

    Ingredients not listed

    The product is made from two or more ingredients and the label appeared not to list the common or usual name of each one (or, for a juice beverage, the percentage of juice).

  • LABELING1 refused line

    Fair Packaging and Labeling Act

    The package appeared not to meet the Fair Packaging and Labeling Act because of the placement, form, or contents of a required label statement.

Questions about Shandong Yuwang Pharmaceutical Co., Ltd

Is Shandong Yuwang Pharmaceutical Co., Ltd on an FDA import alert?
No listing for Shandong Yuwang Pharmaceutical Co., Ltd appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the China page.
Has FDA refused shipments from Shandong Yuwang Pharmaceutical Co., Ltd?
Yes. FDA refused 3 shipment lines from Shandong Yuwang Pharmaceutical Co., Ltd between December 6, 2021 and March 15, 2022. The most recent, on March 15, 2022, was herbals & botanical teas, n.e.c., charged as LIST INGRE (ingredients not listed).
Why did FDA refuse Shandong Yuwang Pharmaceutical Co., Ltd's shipments?
The most frequent charges are LIST INGRE (ingredients not listed, 3 lines) and LABELING (fair packaging and labeling act, 1 line).
When was Shandong Yuwang Pharmaceutical Co., Ltd last inspected by FDA?
FDA's most recent inspection of Shandong Yuwang Pharmaceutical Co., Ltd with a final classification is dated June 29, 2018 and was classified VAI (Voluntary Action Indicated).
What is Shandong Yuwang Pharmaceutical Co., Ltd's FEI number?
Shandong Yuwang Pharmaceutical Co., Ltd's FDA Establishment Identifier (FEI) is 3010119104.

Buying from Shandong Yuwang Pharmaceutical Co., Ltd?

Watch it and get the FDA record the day it changes. Free for one supplier.

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Shandong Yuwang Pharmaceutical Co., Ltd.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectShandong Yuwang Pharmaceutical Co., Lt added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.